GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C&R Research Inc (XKRX:359090) » Definitions » Deferred Tax

C&R Research (XKRX:359090) Deferred Tax : ₩212 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is C&R Research Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

C&R Research's change in deferred tax for the three months ended in Mar. 2024 was ₩7 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2024 was ₩212 Mil.

C&R Research Deferred Tax Historical Data

The historical data trend for C&R Research's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C&R Research Deferred Tax Chart

C&R Research Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Deferred Tax
630.87 579.93 163.79 243.67

C&R Research Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.06 55.18 53.60 95.83 7.05

C&R Research Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩212 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

C&R Research Deferred Tax Related Terms

Thank you for viewing the detailed overview of C&R Research's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

C&R Research (XKRX:359090) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C&R Research Inc (XKRX:359090) » Definitions » Deferred Tax
Comparable Companies
XKRX:347700 XKRX:263700 XKRX:032850 XKRX:390110 XKRX:099750 XKRX:071200 XKRX:226330 XKRX:032620 XKRX:315640 VEEV GEHC TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY EVH TDOC
Traded in Other Exchanges
N/A
Address
412 Yeoksam-ro, C&R Building, Gangnam-gu, Seoul, KOR
Website
http://www.cnrres.com
C&R Research Inc provides a quotation on clinical trial service.

C&R Research (XKRX:359090) Headlines

No Headlines